Leukemia
(UTX-TGR-204) A Multi-Center, Open-Label, Compassionate Use Extension Study of Ublituximab (TG-1101) in Combination with Umbralisib (TGR-1202) for Patients Previously Enrolled in Protocol UTX-TGR-304
- Details
ClinicalTrials.gov ID:
NCT02656303
Diagnosis Type:
CLL
USOR Number:
- Address
2070 W. Rudasill Rd., #130
Tucson, AZ 85704
P: (520) 797-4468